Market Research Report
Biopsy Devices Market Research Report by Product, by Technique, by Application, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
|Published by||360iResearch LLP||Product code||973223|
|Published||Content info||157 Pages
Delivery time: 1-2 business days
|Biopsy Devices Market Research Report by Product, by Technique, by Application, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19|
|Published: November 26, 2020||Content info: 157 Pages||
Biopsy Devices Market Research Report by Product (Localization Wires, Needle-based Biopsy Instruments, and Procedure Trays), by Technique (MRI-guided Biopsy, Stereotactic-guided Biopsy, and Ultrasound-guided Biopsy), by Application, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19.
The Global Biopsy Devices Market is expected to grow from USD 2,016.91 Million in 2019 to USD 3,111.69 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.49%.
Market Segmentation & Coverage:
This research report categorizes the Biopsy Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopsy Devices Market including Angiotech Pharmaceuticals, Inc., Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Group Incorporated, Creganna, Devicor Medical Products, Inc., DTR Medical Ltd, Focal Therapeutics, Inc., Fujifilm Holdings Corporation, Gallini S.r.l., Hologic, INC., Inrad, Inc., Integra LifeSciences Corporation, Leica Biosystems, Medtronic PLC, Olympus Corporation, Precision Biopsy, LLC, Scion Medical Technologies, LLC, and TSK Laboratory Europe BV.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopsy Devices Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
The report provides insights on the following pointers:
The report answers questions such as: